Clinical trials
Recruiting Phase 3 Lymphoma, Large B-Cell, Diffuse trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ruijin Hospital | 2 |
| BeBetter Med Inc | 1 |
| Chengdu Zenitar Biomedical Technology Co., Ltd | 1 |
| Fondazione Italiana Linfomi - ETS | 1 |
| Hutchmed | 1 |
| Lyell Immunopharma, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Nordic Lymphoma Group | 1 |
| Novartis Pharmaceuticals | 1 |
| Ou Bai, MD/PHD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 16 |
| Recurrence | 2 |
| Burkitt Lymphoma | 1 |
| Cardiotoxicity | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
| Heart Failure | 1 |
| Lymphoma | 1 |
| Lymphoma, B-Cell | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.